14:25:56 EDT Fri 07 Aug 2026
Enter Symbol
or Name
USA
CA



Precision Peptide Company Inc (The)
Symbol BPC
Shares Issued 52,431,207
Close 2026-08-06 C$ 0.48
Market Cap C$ 25,166,979
Recent Sedar+ Documents

Precision Peptide "migrates" Amino Innovations store

2026-08-07 11:49 ET - News Release

Mr. Pratap Sandhu reports

THE PRECISION PEPTIDE COMPANY COMPLETES MIGRATION OF AMINO INNOVATIONS ONLINE STORE AND CUSTOMER BASE TO COMPANY WEBSITE

The Precision Peptide Company Inc. has completed the migration of the Amino Innovations on-line supplement store (the Amino Innovations store), including its product catalogue and existing customer base, onto the company's e-commerce platform.

Following the migration, sales through the legacy Amino Innovations store have now ceased, and all traffic is directed to the company platform. The company now manages the point of sale and the customer relationship end to end.

The migration consolidates a seven-product portfolio onto a single company-owned storefront, spanning six wellness categories: recovery, healthy aging, immune support, stress and sleep, hair, and cognitive support. The range comprises The Recovery Patch, a transdermal delivery format, together with BPC, Ageless, KPV, Chill, Hair and Blue. The company expects that presenting the full range in one place may support cross category purchasing and increase average order size among customers who previously purchased from a narrower selection.

The migrated customers are existing purchasers with transaction history as well as further newly generated leads. The company expects that the migrated customers will contribute revenue without the customer acquisition costs ordinarily associated with new customer growth, and now holds the direct customer relationship and the associated first party data, including purchase history and communication preferences. The company intends to use this data to support repeat purchase activity and to evaluate subscription and replenishment offerings.

With the migration complete, the company operates its commercial activity end to end: formulation and product development, manufacturing in an approved United States facility, a single owned storefront, and the direct relationship with the customer. This consolidation also establishes one conversion point for all future marketing activity, and allows the company to operate one storefront, one fulfilment process and one compliance framework rather than maintaining parallel systems.

Pratap Sandhu, chief executive officer of The Precision Peptide Company, commented:

"Owning the storefront and the customer relationship changes what we are able to do as a business. We are no longer only formulating products. We are selling them directly to people who already know them, across a range that now covers seven products in six categories. That is the platform we wanted in place, and our focus now is on serving those customers well and learning how the portfolio performs when it is presented together."

All products offered on the platform are manufactured in an approved facility in the United States and are distributed across North America.

About The Precision Peptide Company Inc.

The Precision Peptide Company is a publicly traded wellness company building a next-generation platform for high-quality peptide formulations. By combining scientific formulation and innovative delivery technologies, the company creates products at the intersection of biotechnology and scalable consumer wellness. Products are manufactured in an approved United States facility and distributed across North America.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.